参考文献/References:
[1].DiBona GF. Sympathetic nervous system and the kidney in hypertension[J]. Curr Opin Nephrol Hypertens,2002,11(2):197-200.
[2].Johns EJ,Kopp UC,DiBona GF. Neural control of renal function[J]. Compr Physiol,2011,1(2):731-767.
[3].Smithwick RH,Porell WJ,Whitelaw GP. Diagnosis of hypertension of adrenal and renal origin[J]. JAMA ,1960,174:127-132.
[4].Esler MD,Krum H,Sobotka PA,et al. Renal sympathetic denervation in patients with treatment-resistant hypertension(The Symplicity HTN-2 Trial):a randomised controlled trial[J]. Lancet,2010,376(9756):1903-1909.
[5].Fadl Elmula FE,Hoffmann P,Larstorp AC,et al. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension[J]. Hypertension,2014,63(5):991-999.
[6].Jin Y,Persu A,Staessen JA. Renal denervation in the management of resistant hypertension:current evidence and perspectives[J]. Curr Opin Nephrol Hypertens,2013,22(5):511-518.
[7].Persu A,Renkin J,Asayama K,et al. Renal denervation in treatment-resistant hypertension:the need for restraint and more and better evidence[J]. Expert Rev Cardiovasc Ther,2013,11(6):739-749.
[8].Tam GM,Yan BP,Shetty SV,et al. Transcatheter renal artery sympathetic denervation for resistant hypertension:an old paradigm revisited[J]. Int J Cardiol,2013,164(3):277-281.
[9].Bhatt DL,Kandzari DE,O’Neill WW,et al. A controlled trial of renal denervation for resistant hypertension[J]. N Engl J Med,2014,370(15):1393-1401.
[10].Esler M,Lambert G,Jennings G. Regional norepinephrine turnover in human hypertension[J]. Clin Exp Hypertens A,1989,11(suppl 1):75-89.
[11].Grassi G,Cattaneo BM,Seravalle G,et al. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension[J]. Hypertension,1998,31(1):68-72.
[12].Grassi G,Seravalle G,Dell’Oro R,et al. Adrenergic and reflex abnormalities in obesity-related hypertension[J]. Hypertension,2000,36(4):538-542.
[13].Papin E,Ambard L. Resection of the nerves of the kidney for nephralgia and small hydronephroses[J]. J Urol,1924,11:337-349.
[14].Adson A,McCraig W,Brown G. Surgery in its relation to hypertension[J]. Surg Gynecol Obstet,1936,62:314-331.
[15].Krum H,Schlaich M,Whitbourn R,et al. Catheter-based renal sympathetic denervation for resistant hypertension:a multicentre safety and proof-of-principle cohort study[J]. Lancet,2009,373(9671):1275-1281.
[16].Townsend RR,Mahfoud F,Kandzari DE,et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications(SPYRAL HTN-OFF MED):a randomised,sham-controlled,proof-of-concept trial[J]. Lancet,2017,390(10108):2160-2170.
[17].Kandzari DE,B?hm M,Mahfoud F,et al. E?ect of renal denervation on blood pressure in the presence of antihypertensive drugs:6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial[J]. Lancet,2018,391(10137):2346-2355.
[18].B?hm M,Kario K,Kandzari DE,et al. E?cacy of catheterbased renal denervation in the absence of antihypertensive medications(SPYRAL HTN-OFF MED Pivotal):a multicentre,randomised,sham-controlled trial[J]. Lancet,2020,395(10234):1444-1451.
[19].Kario K,Yokoi Y,Okamura K,et al. Catheter-based ultrasound renal denervation in patients with resistant hypertension:the randomized,controlled REQUIRE trial[J]. Hypertens Res,2022,45(2):221-231.
[20].Wang J,Sun N,Ge J,et al. Rationale and design of sympathetic mapping/ablation of renal nerves trial(SMART) for the treatment of hypertension:a prospective,multicenter,single-blind,randomized and sham procedure-controlled study[J]. J Cardiovasc Transl Res,2023,16(2):358-370.
[21].Wang L,Li C,Li Z,et al. Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation[J]. J Hypertens,2023,Dec 21.DOI:10.1097/HJH.0000000000003650.?Online ahead of print.
[22].Wilder J. Basimetric approach(law of initial value) to biological rhythms[J]. Ann N Y Acad Sci,1962,98:1211-1220.
[23].施仲伟,冯颖青,林金秀,等. 高血压患者心率管理中国专家共识[J]. 中国医学前沿杂志电子版,2017,9(8):8.
[24].B?hm M,Tsioufis K,Kandzari DE,et al. Effect of heart rate on the outcome of renal denervation in patients with uncontrolled hypertension[J]. J Am Coll Cardiol,2021,78(10):1028-1038.
[25].Mahfoud F,Townsend RR,Kandzari DE,et al. Changes in plasma renin activity after renal artery sympathetic denervation[J]. J Am Coll Cardiol,2021,77(23):2909-2919.
[26].王丽,卢成志,张欣,等. 经导管去肾交感神经术2年随访结果:更适合中青年顽固性高血压患者?[J]. 中华高血压杂志,2015,23(12):1200.
[27].Sata Y,Hering D,Head GA,et al. Ambulatory arterial stiffness index as a predictor of blood pressure response to renal denervation[J]. J Hypertens,2018,36(6):1414-1422.
[28].Kario K,Kim BK,Aoki J,et al. Renal denervation in Asia:consensus statement of the Asia renal denervation consortium[J]. Hypertension,2020,75(3):590-602.
[29].Zeijen VJM,Kroon AA,van den Born BH,et al. The position of renal denervation in treatment of hypertension:an expert consensus statement[J]. Neth Heart J,2023,31(1):3-11.
[30].Barbato E,Azizi M,Schmieder RE,et al. Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC council on hypertension and the European Association of Percutaneous Cardiovascular Interventions(EAPCI)[J]. Eur Heart J,2023,44(15):1313-1330.
[31].Lin HJ,Wang TD,Yu-Chih Chen M,et al. 2020 Consensus statement of the Taiwan Hypertension S ociety and the Taiwan Society of Cardiology on home blood pressure monitoring for the management of arterial hypertension[J]. Acta Cardiol Sin,2020,36(6):537-561.
相似文献/References:
[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(3):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(3):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[3]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(3):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[4]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(3):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[5]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(3):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[6]黄秋瑾 胡蓉.高血压合并糖尿病患者血压控制率和控制目标的探讨[J].心血管病学进展,2019,(7):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
HUANG QiujinHU Rong.Discussion on Blood Pressure Control Rate and Control Target in Patients with Hypertension Complicated with Diabetes[J].Advances in Cardiovascular Diseases,2019,(3):973.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.002]
[7]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(3):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[8]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[9]肖蓉雪 刘宗军.肾动脉去交感神经术治疗顽固性高血压的研究进展[J].心血管病学进展,2019,(8):1138.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.017]
XIAO Rongxue,LIU Zongjun.Treatment of Resistant Hypertension by Renal Denervation[J].Advances in Cardiovascular Diseases,2019,(3):1138.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.017]
[10]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(3):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[11]董一飞 张毅 李燕 贾楠.经皮去肾神经术治疗高血压的临床获益：证据和争议[J].心血管病学进展,2024,(10):890.[doi:10.16806/j.cnki.issn.1004-3934.2024.10.006]
DONG Yifei,ZHANG Yi,LI Yan,et al.Clinical Benefit of Renal Denervation In the Treatment of Hypertension:Evidence And Controversy[J].Advances in Cardiovascular Diseases,2024,(3):890.[doi:10.16806/j.cnki.issn.1004-3934.2024.10.006]